Revolution Medicines, Inc. (RVMD) FY2025 Annual P&L / Income Statement

Revolution Medicines, Inc. (RVMD) FY2025 Annual P&L / Income Statement

Income statement for 2025-01-01 through 2025-12-31. Consolidated revenue, costs and expenses.

Total revenue

0 US dollars

Total operating expenses

1,182,369,000 US dollars

Loss from operations

negative 1,182,369,000 US dollars

Total non-operating income, net

51,068,000 US dollars

Income (loss) before provision for income taxes

negative 1,131,301,000 US dollars

Benefit from income taxes

0 US dollars

Net loss

negative 1,131,301,000 US dollars

Total operating expenses

1,182,369,000 US dollars

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.